Literature DB >> 19551303

Gigantism of the lower limb in Klippel-Trenaunay syndrome: anatomy of the lateral marginal vein.

N R Abdul-Rahman1, K F Mohammad, S Ibrahim.   

Abstract

The Klippel-Trenaunay syndrome is a combination of venous and capillary malformations associated with soft tissue and/or bony limb hypertrophy, with or without lymphatic malformations. Although persistent foetal veins are rare, the persistence of the lateral marginal vein is a common association in this syndrome. It results in venous hypertension, which gives rise to venous varicosities, which are commonly seen in this syndrome. This is a case report of a 28-year-old man with Klippel-Trenaunay syndrome, with persistence of the lateral marginal vein, affecting his right lower limb. He was treated with an above-knee amputation. The amputated limb was dissected to demonstrate the anatomy of the lateral marginal vein. To the best of the authors' knowledge, the gross anatomy of the lateral marginal vein has not been previously reported.

Entities:  

Mesh:

Year:  2009        PMID: 19551303

Source DB:  PubMed          Journal:  Singapore Med J        ISSN: 0037-5675            Impact factor:   1.858


  4 in total

1.  Klippel-Trenaunay Syndrome: a case report with brief review of literature.

Authors:  Mohammad Iqbal Zea; Mohammad Hanif; Mohammad Habib; Ahmed Ansari
Journal:  J Dermatol Case Rep       Date:  2009-12-30

Review 2.  Intraneural hemangioma in Klippel-Trenaunay syndrome: role of musculo-skeletal ultrasound in diagnosis-case report and review of the literature.

Authors:  Jeena Bordoloi Deka; Nilim Kumar Deka; Mohit V Shah; Nidhi Bhatnagar; Anna Lisa Nanni; Fernando Jimenez
Journal:  J Ultrasound       Date:  2020-02-20

3.  Mystery of a giant leg.

Authors:  M R Siddiqui; Q T Islam; A Hossain
Journal:  BMJ Case Rep       Date:  2010-10-21

4.  A case of concurrent proteus syndrome and hemophilia a.

Authors:  Mozhgan Hashemieh; Bahar Mansoori; Reza Tavakoli; Koroush Sheibani
Journal:  Iran J Pediatr       Date:  2012-06       Impact factor: 0.364

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.